Long Pentraxin PTX3 Exacerbates Pressure Overload-Induced Left Ventricular Dysfunction

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Suzuki, Satoshi ^a,b   Shishido, Tetsuro ^a   Funayama, Akira ^a   Netsu, Shunsuke ^a   Ishino, Mitsunori ^a   Kitahara, Tatsuro ^a   Sasaki, Toshiki ^a   Katoh, Shigehiko ^a   Otaki, Yoichiro ^a   Watanabe, Tetsu ^a   Shibata, Yoko ^a   Mantovani, Alberto ^c   Takeishi, Yasuchika ^b   Kubota, Isao ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; COLLAGEN TYPE 1; COLLAGEN TYPE 2; CONNECTIVE TISSUE GROWTH FACTOR; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN BETA; PENTRAXIN 3; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; ECHOCARDIOGRAPHY; EMBRYO; ENZYME PHOSPHORYLATION; FETUS; FIBROSING ALVEOLITIS; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE SILENCING; GENOTYPE; HEART AFTERLOAD; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OVERLOAD; HEART VENTRICLE REMODELING; HUMAN; MOUSE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PTX3 GENE;

ANIMALS; AORTA; C-REACTIVE PROTEIN; CONNECTIVE TISSUE GROWTH FACTOR; CONSTRICTION, PATHOLOGIC; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROSIS; GENE EXPRESSION REGULATION; HUMANS; HYDROGEN PEROXIDE; HYPERTROPHY, LEFT VENTRICULAR; INTERLEUKIN-6; MICE; MICE, TRANSGENIC; MYOCARDIUM; MYOCYTES, CARDIAC; MYOFIBROBLASTS; NERVE TISSUE PROTEINS; NF-KAPPA B; PHOSPHORYLATION; SIGNAL TRANSDUCTION; VENTRICULAR DYSFUNCTION, LEFT;

MUS; MUS MUSCULUS;

EID: 84872811309     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053133     Document Type: Article

References (40)

1. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK, (1996) The progression from hypertension to congestive heart failure. JAMA 275: 1557-1562.
2. Nozaki N, Shishido T, Takeishi Y, Kubota I, (2004) Modulation of doxorubicin-induced cardiac dysfunction in toll-like receptor-2-knockout mice. Circulation 110: 2869-2874.
3. Shishido T, Konta T, Nishiyama S, Miyashita T, Miyamoto T, et al. (2011) Suppressive Effects of Valsartan on Microalbuminuria and CRP in Patients with Metabolic Syndrome (Val-Mets). Clin Exp Hypertens 33: 117-123.
4. Sun M, Chen M, Dawood F, Zurawska U, Li JY, et al. (2007) Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state. Circulation 115: 1398-1407.
5. Kodama H, Fukuda K, Pan J, Sano M, Takahashi T, et al. (2000) Significance of ERK cascade compared with JAK/STAT and PI3-K pathway in gp130-mediated cardiac hypertrophy. Am J Physiol Heart Circ Physiol 279: H1635-1644.
6. Kunisada K, Tone E, Fujio Y, Matsui H, Yamauchi-Takihara K, et al. (1998) Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes. Circulation 98: 346-352.
7. Rauchhaus M, Doehner W, Francis DP, Davos C, Kemp M, et al. (2000) Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 102: 3060-3067.
8. Yin WH, Chen JW, Jen HL, Chiang MC, Huang WP, et al. (2004) Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure. Am Heart J 147: 931-938.
9. Bottazzi B, Doni A, Garlanda C, Mantovani A, (2010) An integrated view of humoral innate immunity: pentraxins as a paradigm. Annu Rev Immunol 28: 157-183.
10. Steel DM, Whitehead AS, (1994) The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 15: 81-88.
11. Basile A, Sica A, d'Aniello E, Breviario F, Garrido G, et al. (1997) Characterization of the promoter for the human long pentraxin PTX3. Role of NF-kappaB in tumor necrosis factor-alpha and interleukin-1beta regulation. J Biol Chem 272: 8172-8178.
12. Garlanda C, Bottazzi B, Bastone A, Mantovani A, (2005) Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol 23: 337-366.
13. Suzuki S, Takeishi Y, Niizeki T, Koyama Y, Kitahara T, et al. (2008) Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure. Am Heart J 155: 75-81.
14. Salio M, Chimenti S, De Angelis N, Molla F, Maina V, et al. (2008) Cardioprotective function of the long pentraxin PTX3 in acute myocardial infarction. Circulation 117: 1055-1064.
15. Arimoto T, Takeishi Y, Takahashi H, Shishido T, Niizeki T, et al. (2006) Cardiac-specific overexpression of diacylglycerol kinase zeta prevents Gq protein-coupled receptor agonist-induced cardiac hypertrophy in transgenic mice. Circulation 113: 60-66.
16. Woo CH, Le NT, Shishido T, Chang E, Lee H, et al. (2010) Novel role of C terminus of Hsc70-interacting protein (CHIP) ubiquitin ligase on inhibiting cardiac apoptosis and dysfunction via regulating ERK5-mediated degradation of inducible cAMP early repressor. FASEB J 24: 4917-4928.
17. Harada M, Takeishi Y, Arimoto T, Niizeki T, Kitahara T, et al. (2007) Diacylglycerol kinase zeta attenuates pressure overload-induced cardiac hypertrophy. Circ J 71: 276-282.
18. Shishido T, Nozaki N, Yamaguchi S, Shibata Y, Nitobe J, et al. (2003) Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction. Circulation 108: 2905-2910.
19. Shishido T, Woo CH, Ding B, McClain C, Molina CA, et al. (2008) Effects of MEK5/ERK5 association on small ubiquitin-related modification of ERK5: implications for diabetic ventricular dysfunction after myocardial infarction. Circ Res 102: 1416-1425.
20. Yan C, Ding B, Shishido T, Woo CH, Itoh S, et al. (2007) Activation of extracellular signal-regulated kinase 5 reduces cardiac apoptosis and dysfunction via inhibition of a phosphodiesterase 3A/inducible cAMP early repressor feedback loop. Circ Res 100: 510-519.
21. Souza DG, Amaral FA, Fagundes CT, Coelho FM, Arantes RM, et al. (2009) The long pentraxin PTX3 is crucial for tissue inflammation after intestinal ischemia and reperfusion in mice. Am J Pathol 174: 1309-1318.
22. Devaraj S, Du Clos TW, Jialal I, (2005) Binding and internalization of C-reactive protein by Fcgamma receptors on human aortic endothelial cells mediates biological effects. Arterioscler Thromb Vasc Biol 25: 1359-1363.
23. Chen MM, Lam A, Abraham JA, Schreiner GF, Joly AH, (2000) CTGF expression is induced by TGF- beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis. J Mol Cell Cardiol 32: 1805-1819.
24. Wenzel S, Henning K, Habbig A, Forst S, Schreckenberg R, et al. (2010) TGF-beta1 improves cardiac performance via up-regulation of laminin receptor 37/67 in adult ventricular cardiomyocytes. Basic Res Cardiol 105: 621-629.
25. Katoh S, Shishido T, Kutsuzawa D, Arimoto T, Netsu S, et al. (2010) Iodine-123-metaiodobenzylguanidine imaging can predict future cardiac events in heart failure patients with preserved ejection fraction. Ann Nucl Med 24: 679-686.
26. Peri G, Introna M, Corradi D, Iacuitti G, Signorini S, et al. (2000) PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans. Circulation 102: 636-641.
27. Introna M, Alles VV, Castellano M, Picardi G, De Gioia L, et al. (1996) Cloning of mouse ptx3, a new member of the pentraxin gene family expressed at extrahepatic sites. Blood 87: 1862-1872.
28. Sasaki T, Takeishi Y, Suzuki S, Niizeki T, Kitahara T, et al. (2010) High serum level of neopterin is a risk factor of patients with heart failure. Int J Cardiol.
29. Kitahara T, Shishido T, Suzuki S, Katoh S, Sasaki T, et al. (2010) Serum midkine as a predictor of cardiac events in patients with chronic heart failure. J Card Fail 16: 308-313.
30. Bilim O, Takeishi Y, Kitahara T, Ishino M, Sasaki T, et al. (2010) Serum YKL-40 predicts adverse clinical outcomes in patients with chronic heart failure. J Card Fail 16: 873-879.
31. Cirillo P, Golino P, Calabro P, Cali G, Ragni M, et al. (2005) C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation. Cardiovasc Res 68: 47-55.
32. Nagai T, Anzai T, Kaneko H, Mano Y, Anzai A, et al. (2011) C-reactive protein overexpression exacerbates pressure overload-induced cardiac remodeling through enhanced inflammatory response. Hypertension 57: 208-215.
33. Lu J, Marnell LL, Marjon KD, Mold C, Du Clos TW, et al. (2008) Structural recognition and functional activation of FcgammaR by innate pentraxins. Nature 456: 989-992.
34. Takeishi Y, Huang Q, Abe J, Glassman M, Che W, et al. (2001) Src and multiple MAP kinase activation in cardiac hypertrophy and congestive heart failure under chronic pressure-overload: comparison with acute mechanical stretch. J Mol Cell Cardiol 33: 1637-1648.
35. Baldwin AS Jr, (1996) The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 14: 649-683.
36. Hattori Y, Matsumura M, Kasai K, (2003) Vascular smooth muscle cell activation by C-reactive protein. Cardiovasc Res 58: 186-195.
37. Yokoyama T, Sekiguchi K, Tanaka T, Tomaru K, Arai M, et al. (1999) Angiotensin II and mechanical stretch induce production of tumor necrosis factor in cardiac fibroblasts. Am J Physiol 276: H1968-1976.
38. Sano M, Fukuda K, Kodama H, Pan J, Saito M, et al. (2000) Interleukin-6 family of cytokines mediate angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes. J Biol Chem 275: 29717-29723.
39. Barrick CJ, Rojas M, Schoonhoven R, Smyth SS, Threadgill DW, (2007) Cardiac response to pressure overload in 129S1/SvImJ and C57BL/6J mice: temporal- and background-dependent development of concentric left ventricular hypertrophy. Am J Physiol Heart Circ Physiol 292: H2119-2130.
40. Massett MP, Berk BC, (2005) Strain-dependent differences in responses to exercise training in inbred and hybrid mice. Am J Physiol Regul Integr Comp Physiol 288: R1006-1013.